Issue 4 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

24

No.

4

April 27, 2001Apr 27, 2001

Free

DOWNLOAD THE PDF

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

Wilms’ Tumor Survivors At High Risk Of Heart Failure

Cancer Pain Treatment Guide Published By NCCN, ACS

Without Advance Directives, Families Prolong Treatment

Long-Term Estrogen Use May Increase Ovarian Cancer Risk

Natural Substance Blocks Androgen Activity In Vitro

NCI-Approved Clinical Trials Listed For Month Of March

Recent Issues

Volume 52 | Issue 26 - July 02, 2026

Volume 52 | Issue 25 - June 26, 2026

Volume 52 | Issue 24 - June 18, 2026

Volume 52 | Issue 23 - June 12, 2026

Volume 52 | Issue 22 - June 05, 2026

Volume 52 | Issue 21 - May 29, 2026